Stemtech Corporation
STEK · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,951 | $3,846 | $3,935 | $5,496 |
| - Cash | $255 | $272 | $306 | $255 |
| + Debt | $2,361 | $4,141 | $4,165 | $3,816 |
| Enterprise Value | $4,057 | $7,714 | $7,794 | $9,056 |
| Revenue | $852 | $698 | $868 | $1,314 |
| % Growth | 22.1% | -19.6% | -33.9% | – |
| Gross Profit | $682 | $552 | $720 | $1,045 |
| % Margin | 80.1% | 79.1% | 83% | 79.6% |
| EBITDA | -$214 | -$175 | -$1,171 | $157 |
| % Margin | -25.1% | -25% | -135% | 11.9% |
| Net Income | -$3 | -$293 | -$1,456 | -$397 |
| % Margin | -0.4% | -42% | -167.7% | -30.2% |
| EPS Diluted | -0.01 | -0.002 | -0.01 | -0.003 |
| % Growth | -376.2% | 79% | -244.8% | – |
| Operating Cash Flow | $25 | $75 | -$711 | -$1,020 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $25 | $75 | -$711 | -$1,020 |